TorHoerman Law Advocates for Infants in Pivotal Missouri NEC Trial Against Formula Manufacturers

ST. LOUIS, July 3, 2024 /PRNewswire/ -- TorHoerman Law is set to begin trial on July 8, 2024, in Missouri state court. The case will focus on allegations that cow milk-based baby formula is linked to

PR NewswireJul 4 01:31

Abbott Labs Is Maintained at Outperform by Evercore ISI Group

Abbott Labs Is Maintained at Outperform by Evercore ISI Group

Dow JonesJul 2 23:05

7 Analysts Have This To Say About Abbott Laboratories

Analysts' ratings for Abbott Laboratories (NYSE:ABT) over the last quarter vary from bullish to bearish, as provided by 7 analysts.The following table provides a quick overview of their recent ratings

BenzingaJul 2 23:02

Abbott Laboratories Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/02/2024 16.35% Evercore ISI Group $125 → $120 Maintains Outperform 06/04/2024 21.19% RBC Capital $125 →

BenzingaJul 2 22:55

Evercore Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $120

Evercore analyst Vijay Kumar maintains $Abbott Laboratories(ABT.US)$ with a buy rating, and maintains the target price at $120.According to TipRanks data, the analyst has a success rate of 47.4% and a

Futu NewsJul 2 20:31 · Ratings

Evercore ISI Adjusts Price Target on Abbott Laboratories to $120 From $125, Maintains Outperform Rating

Abbott Laboratories (ABT) has an average rating of outperform and price targets ranging from $104 to $143, according to analysts polled by Capital IQ.

MT NewswiresJul 2 19:44